Consumer Genomics Market Size to Hit USD 10.8 Billion by 2032, Growing at a 24.6% CAGR - SNS Insider
January 31, 2025 09:50 ET
|
SNS Insider pvt ltd
Pune, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Global Consumer Genomics Market Size & Growth Analysis: “According to SNS Insider, the global Consumer Genomics Market size was valued at USD 1.5 Billion...
Genotyping Market Size is Expected to Reach USD 70.85 Billion by 2033, Growing at a CAGR of 14.32%: Straits Research
January 22, 2025 10:20 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Genotyping involves analyzing DNA sequences to ascertain the genetic makeup of the genotypes of living things, such as people, plants,...
CRISPR-based Gene Editing Market Report 2025, with Company Profiles of the Top 10+ Major Market Players
January 13, 2025 11:45 ET
|
Research and Markets
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "CRISPR-based Gene Editing Market by Product & Service, by Application, by End-User, and By Region" report has been added to ...
ERS Genomics launches ‘Express License’ platform to democratise access to CRISPR/Cas9
January 13, 2025 09:00 ET
|
ERS Genomics
ERS Genomics (‘ERS’), the CRISPR licensing company, today announces the launch of its Express License platform.
Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025
January 12, 2025 19:05 ET
|
Caribou Biosciences, Inc.
-- CB-010 GALLOP Phase 1 trial initiated in lupus -- -- CB-012 AMpLify Phase 1 trial in r/r AML completes dose level 3 with no DLTs; enrolling patients at dose level 4 -- -- CB-010 ANTLER 2L LBCL...
Caribou Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 07, 2025 16:00 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced that Rachel...
Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer
January 02, 2025 08:00 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the...
Cell and Gene Therapies Current and Future Landscape 2025-2030
January 02, 2025 05:05 ET
|
Research and Markets
Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapies - Current and Future Landscape" report has been added to ResearchAndMarkets.com's offering.The global CGT market is expected...
Growth Trends in the CRISPR and Cas Gene Market: Industry Opportunities and Strategies to 2028 & 2033
December 13, 2024 09:27 ET
|
Research and Markets
Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- The "CRISPR and Cas Gene Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering.This report describes and...
Gene Editing Market Forecast Report 2024, with Profiles of Merck, GenScript, Revvity, Lonza, Precision BioSciences, Cellectis, AMSBIO, Synthego, Takara Bio, Bio-Techne, Reprocell and More
November 29, 2024 04:43 ET
|
Research and Markets
Dublin, Nov. 29, 2024 (GLOBE NEWSWIRE) -- The "Gene Editing Market by Product (Kits, Reagents, Libraries, Software), Services (GRNA Synthesis & Vector Construction), Technique, Technology...